KLOW

KLOW is a four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV.

KLOW contains GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg). Each component has a distinct molecular structure and research profile.

Research involving the individual components has examined tissue biology, cellular signaling, inflammatory pathways, extracellular-matrix remodeling, and skin biology.

The formulation brings together four peptides that have been investigated across complementary areas of biological research. The combined formulation remains distinct from research involving each individual component.

Research findings vary according to the individual peptide, experimental model, study design, formulation, concentration, and specific endpoint being measured. Findings from individual components should not automatically be assumed to apply to the combined formulation.

Available batch-specific testing information can be found through the Batch Results section of the Whitey’s Peps website.